Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
IDXXIdexx Laboratories
FinDog View：Bullish
| Metric | GILD | IDXX |
|---|
| Close | 170.68 | 551.21 |
| Market Cap | $213B | $43.9B |
| 1M | +14.51% | +5.56% |
| P/E (TTM) | — | 38.9 |
| Forward P/E | 22.0 | 32.2 |
| P/E 5-Yr Percentile | — | 7 |
| P/S | 7.0 | 9.8 |
| P/B | 17.9 | 27.5 |
| Dividend Yield | 3.98% | — |
| Latest Quarter Revenue | $8.3B | $1.2B |
| Revenue YoY | +6.8% | +9.7% |
| Gross Margin | 81.1% | 64.0% |
| Latest Quarter EPS | 1.94 | 4.27 |
| Avg Post-Earnings Move | ±3.8% | ±1.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.57% | 2.68% |
| 90-Day Net Insider Buying | −$15.9M | −$1.2M |
GILD · Revenue, Last 8 Quarters ($B)
IDXX · Revenue, Last 8 Quarters ($B)
